Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haffner

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Science Advances|October 7, 2022
Oncogenic role of a developmentally regulated <i>NTRK2</i> splice variantSiobhan S Pattwell, Sonali Arora, Nicholas Nuechterlein, et al.
NPJ Precision Oncology|August 15, 2023
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason gradingYuri Tolkach, Vlado Ovtcharov, Alexey Pryalukhin, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancer Research|August 22, 2015
Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic ProgressionPaula J Hurley, Robert M Hughes, Brian W Simons, et al.
Cancer Research Communications|November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterationsRadhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Prostate Cancer and Prostatic Diseases|December 23, 2022
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Todd Yezefski, et al.
Cancer Research|May 25, 2019
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic ProgressionRobert M Hughes, Brian W Simons, Hamda Khan, et al.
Scientific Reports|April 8, 2016
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneityQing Zhong, Jan H Rüschoff, Tiannan Guo, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
JCO Precision Oncology|April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort StudyRuben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Science Advances|October 7, 2022
Oncogenic role of a developmentally regulated <i>NTRK2</i> splice variantSiobhan S Pattwell, Sonali Arora, Nicholas Nuechterlein, et al.
NPJ Precision Oncology|August 15, 2023
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason gradingYuri Tolkach, Vlado Ovtcharov, Alexey Pryalukhin, et al.
Cancer Research|July 27, 2021
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate CancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancer Research|August 22, 2015
Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic ProgressionPaula J Hurley, Robert M Hughes, Brian W Simons, et al.
Cancer Research Communications|November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterationsRadhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Prostate Cancer and Prostatic Diseases|December 23, 2022
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Todd Yezefski, et al.
Cancer Research|May 25, 2019
Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic ProgressionRobert M Hughes, Brian W Simons, Hamda Khan, et al.
Scientific Reports|April 8, 2016
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneityQing Zhong, Jan H Rüschoff, Tiannan Guo, et al.
JCI Insight|May 23, 2022
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistromeXintao Qiu, Lisha G Brown, Jennifer L Conner, et al.
Pageof 21